BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taleb SA, Al Thani AA, Al Ansari K, Yassine HM. Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches. Eur J Clin Microbiol Infect Dis 2018;37:1817-27. [PMID: 29876771 DOI: 10.1007/s10096-018-3289-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Zhao J, Zou X, Fan Y, Xiong Z, Li B, Wang C, Li H, Han J, Liu X, Xia Y, Lu B, Cao B; CAP-China network. Severity of influenza virus and respiratory syncytial virus coinfections in hospitalized adult patients. J Clin Virol 2020;133:104685. [PMID: 33220548 DOI: 10.1016/j.jcv.2020.104685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Alsayari A, Muhsinah AB, Almaghaslah D, Annadurai S, Wahab S. Pharmacological Efficacy of Ginseng against Respiratory Tract Infections. Molecules 2021;26:4095. [PMID: 34279434 DOI: 10.3390/molecules26134095] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cai W, Tolksdorf K, Hirve S, Schuler E, Zhang W, Haas W, Buda S. Evaluation of using ICD-10 code data for respiratory syncytial virus surveillance. Influenza Other Respir Viruses 2020;14:630-7. [PMID: 31206246 DOI: 10.1111/irv.12665] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
4 Yassine HM, Sohail MU, Younes N, Nasrallah GK. Systematic Review of the Respiratory Syncytial Virus (RSV) Prevalence, Genotype Distribution, and Seasonality in Children from the Middle East and North Africa (MENA) Region. Microorganisms 2020;8:E713. [PMID: 32403364 DOI: 10.3390/microorganisms8050713] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
5 Citron MP, McAnulty J, Callahan C, Knapp W, Fontenot J, Morales P, Flynn JA, Douglas CM, Espeseth AS. Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs. Pathogens 2021;10:1441. [PMID: 34832599 DOI: 10.3390/pathogens10111441] [Reference Citation Analysis]
6 Bianchini S, Silvestri E, Argentiero A, Fainardi V, Pisi G, Esposito S. Role of Respiratory Syncytial Virus in Pediatric Pneumonia. Microorganisms 2020;8:E2048. [PMID: 33371276 DOI: 10.3390/microorganisms8122048] [Reference Citation Analysis]
7 Löwensteyn YN, Phijffer EWEM, Simons JVL, Scheltema NM, Mazur NI, Nair H, Bont LJ; RSV GOLD Study Group. Respiratory Syncytial Virus-related Death in Children With Down Syndrome: The RSV GOLD Study. Pediatr Infect Dis J 2020;39:665-70. [PMID: 32332221 DOI: 10.1097/INF.0000000000002666] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
8 O'Grady KF, Cripps AW, Grimwood K. Paediatric and adult bronchiectasis: Vaccination in prevention and management. Respirology 2019;24:107-14. [PMID: 30477047 DOI: 10.1111/resp.13446] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
9 Hijano DR, Vu LD, Kauvar LM, Tripp RA, Polack FP, Cormier SA. Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity. Front Immunol 2019;10:566. [PMID: 30972063 DOI: 10.3389/fimmu.2019.00566] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
10 Behzadi MA, Leyva-Grado VH. Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections. Front Microbiol 2019;10:1327. [PMID: 31275265 DOI: 10.3389/fmicb.2019.01327] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 15.7] [Reference Citation Analysis]
11 Grant T, Brigham EP, McCormack MC. Childhood Origins of Adult Lung Disease as Opportunities for Prevention. J Allergy Clin Immunol Pract 2020;8:849-58. [PMID: 32147138 DOI: 10.1016/j.jaip.2020.01.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
12 Xing Y, Proesmans M. New therapies for acute RSV infections: where are we? Eur J Pediatr 2019;178:131-8. [PMID: 30610420 DOI: 10.1007/s00431-018-03310-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
13 van Eeden C, Khan L, Osman MS, Cohen Tervaert JW. Natural Killer Cell Dysfunction and Its Role in COVID-19. Int J Mol Sci 2020;21:E6351. [PMID: 32883007 DOI: 10.3390/ijms21176351] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
14 Vázquez Y, González L, Noguera L, González PA, Riedel CA, Bertrand P, Bueno SM. Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update. Front Immunol 2019;10:1154. [PMID: 31214165 DOI: 10.3389/fimmu.2019.01154] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
15 Smatti MK, Al Thani AA, Yassine HM. Viral-Induced Enhanced Disease Illness. Front Microbiol. 2018;9:2991. [PMID: 30568643 DOI: 10.3389/fmicb.2018.02991] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 18.8] [Reference Citation Analysis]
16 O'Brien B, Goodridge L, Ronholm J, Nasheri N. Exploring the potential of foodborne transmission of respiratory viruses. Food Microbiol 2021;95:103709. [PMID: 33397626 DOI: 10.1016/j.fm.2020.103709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ananworanich J, Heaton PM. Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities. Vaccines (Basel) 2021;9:961. [PMID: 34579198 DOI: 10.3390/vaccines9090961] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Noor F, Ali Ashfaq U, Rizwan Javed M, Hamzah Saleem M, Ahmad A, Farhan Aslam M, Aslam S. Comprehensive computational analysis reveals human respiratory syncytial virus encoded microRNA and host specific target genes associated with antiviral immune responses and protein binding. Journal of King Saud University - Science 2021;33:101562. [DOI: 10.1016/j.jksus.2021.101562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
19 Mathew S, Taleb S, Eid AH, Althani AA, Yassine HM. In silico virtual screening of lead compounds for major antigenic sites in respiratory syncytial virus fusion protein. Emergent Mater 2021;:1-11. [PMID: 33969268 DOI: 10.1007/s42247-021-00213-6] [Reference Citation Analysis]
20 Crofts KF, Alexander-Miller MA. Challenges for the Newborn Immune Response to Respiratory Virus Infection and Vaccination. Vaccines (Basel) 2020;8:E558. [PMID: 32987691 DOI: 10.3390/vaccines8040558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
21 Nam HH, Ison MG. Respiratory syncytial virus infection in adults. BMJ. [DOI: 10.1136/bmj.l5021] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 13.0] [Reference Citation Analysis]
22 Cai W, Buda S, Schuler E, Hirve S, Zhang W, Haas W. Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomes. Influenza Other Respir Viruses 2020;14:658-70. [PMID: 32064773 DOI: 10.1111/irv.12729] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
23 Nyiro JU, Kiyuka PK, Mutunga MN, Sande CJ, Munywoki PK, Scott JAG, Nokes DJ. Agreement between ELISA and plaque reduction neutralisation assay in Detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal Kenya. Wellcome Open Res 2019;4:33. [PMID: 30906883 DOI: 10.12688/wellcomeopenres.15108.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Sarkar I, Zardini Buzatto A, Garg R, Li L, van Drunen Littel-van den Hurk S. Metabolomic and Immunological Profiling of Respiratory Syncytial Virus Infection after Intranasal Immunization with a Subunit Vaccine Candidate. J Proteome Res 2019;18:1145-61. [PMID: 30706717 DOI: 10.1021/acs.jproteome.8b00806] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
25 A Al-Sharif H, El-Kafrawy SA, Yousef JM, Kumosani TA, Kamal MA, Khathlan NA, Kaki RM, Alnajjar AA, Azhar EI. Dominance of the ON1 Genotype of RSV-A and BA9 Genotype of RSV-B in Respiratory Cases from Jeddah, Saudi Arabia. Genes (Basel) 2020;11:E1323. [PMID: 33182267 DOI: 10.3390/genes11111323] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Bergeron HC, Tripp RA. Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV). Expert Opin Investig Drugs 2021;:1-7. [PMID: 34937485 DOI: 10.1080/13543784.2022.2020248] [Reference Citation Analysis]
27 He L, Yang L, Zhang H, Luo Q. Efficacy and safety of interferon on neonates with respiratory syncytial virus pneumonia. Exp Ther Med 2020;20:220. [PMID: 33193835 DOI: 10.3892/etm.2020.9350] [Reference Citation Analysis]
28 Nam HH, Ison MG. Respiratory Syncytial Virus. Semin Respir Crit Care Med 2021;42:788-99. [PMID: 34918321 DOI: 10.1055/s-0041-1736182] [Reference Citation Analysis]
29 Wu Y, Qu Z, Xiong R, Yang Y, Liu S, Nie J, Liang C, Huang W, Wang Y, Fan C. A practical method for evaluating the in vivo efficacy of EVA-71 vaccine using a hSCARB2 knock-in mouse model. Emerg Microbes Infect 2021;10:1180-90. [PMID: 34044752 DOI: 10.1080/22221751.2021.1934558] [Reference Citation Analysis]
30 Paes B, Carbonell-estrany X. Respiratory syncytial virus prophylaxis for children with chronic lung disease: have we got the criteria right? Expert Review of Anti-infective Therapy 2019;17:211-22. [DOI: 10.1080/14787210.2019.1581062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]